Lung Cancer Surveillance for Patients With Head and Neck Cancer.

Area of Science:

• Oncology
• Radiology
• Pulmonology

Background:

• Patients with head and neck squamous cell cancer (HNSCC) have an increased risk of pulmonary metastases and secondary lung cancers.
• The survival benefit of lung cancer screening in HNSCC patients with negative initial staging is not well-established.

Purpose of the Study:

• To compare the effectiveness of chest radiography versus low-dose computed tomography (LDCT) for screening pulmonary metastases and second primary lung cancer in HNSCC patients.
• To evaluate the impact of these screening methods on long-term cancer survival outcomes.

Main Methods:

• A randomized parallel trial involving 137 treatment-naive HNSCC patients who did not meet US National Comprehensive Cancer Network (NCCN) lung screening criteria.
• Participants were randomized to either chest radiography or LDCT screening.
• Data were analyzed for lung cancer detection rates, overall survival, and disease-free survival.

Main Results:

• LDCT demonstrated superior sensitivity (100%) and specificity (100%) for detecting lung metastases and second primary lung cancer compared to chest radiography (sensitivity 66.7%, specificity 100%).
• Despite higher detection rates with LDCT, no significant differences in overall survival or disease-free survival were observed between the two groups.
• 6.5% of patients developed either a second primary lung cancer or lung metastases during the study period.

Conclusions:

• LDCT is significantly more sensitive than chest radiography for detecting pulmonary complications in HNSCC patients.
• While LDCT improves diagnostic accuracy, current evidence from this trial does not support a survival benefit for either screening method in this specific patient group.
• These findings provide valuable information for clinicians making decisions about lung screening protocols for HNSCC patients.